- Home
- GNFT vs RDCM Comparison
GNFT vs RDCM Comparison
Compare GNFT & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- RDCM
- Stock Information
- Founded
- GNFT 1999
- RDCM 1985
- Country
- GNFT France
- RDCM Israel
- Employees
- GNFT N/A
- RDCM N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- RDCM Computer peripheral equipment
- Sector
- GNFT Health Care
- RDCM Technology
- Exchange
- GNFT Nasdaq
- RDCM Nasdaq
- Market Cap
- GNFT 186.3M
- RDCM 206.0M
- IPO Year
- GNFT 2019
- RDCM 1997
- Fundamental
- Price
- GNFT $4.14
- RDCM $14.50
- Analyst Decision
- GNFT Strong Buy
- RDCM Strong Buy
- Analyst Count
- GNFT 1
- RDCM 2
- Target Price
- GNFT $13.00
- RDCM $16.00
- AVG Volume (30 Days)
- GNFT 4.0K
- RDCM 80.4K
- Earning Date
- GNFT 09-18-2025
- RDCM 08-13-2025
- Dividend Yield
- GNFT N/A
- RDCM N/A
- EPS Growth
- GNFT N/A
- RDCM 111.69
- EPS
- GNFT 0.03
- RDCM 0.53
- Revenue
- GNFT $73,187,701.00
- RDCM $63,477,000.00
- Revenue This Year
- GNFT $15.98
- RDCM $18.09
- Revenue Next Year
- GNFT N/A
- RDCM $11.46
- P/E Ratio
- GNFT $132.83
- RDCM $26.54
- Revenue Growth
- GNFT 105.01
- RDCM 18.21
- 52 Week Low
- GNFT $2.55
- RDCM $9.19
- 52 Week High
- GNFT $6.42
- RDCM $15.98
- Technical
- Relative Strength Index (RSI)
- GNFT 58.36
- RDCM 61.15
- Support Level
- GNFT $3.94
- RDCM $13.49
- Resistance Level
- GNFT $4.20
- RDCM $14.50
- Average True Range (ATR)
- GNFT 0.13
- RDCM 0.72
- MACD
- GNFT 0.05
- RDCM 0.11
- Stochastic Oscillator
- GNFT 91.62
- RDCM 95.24
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.